AC
UNH icon

Abbrea Capital’s UnitedHealth UNH Stock Holding History

Abbrea Capital’s Portfolio UNH Stock Details UNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.78M Sell
7,422
-379
-5% -$186K 0.5% 44
2024
Q1 		$3.86M Buy
7,801
+156
+2% +$79.3K 0.51% 42
2023
Q4 		$4.03M Buy
7,645
+245
+3% +$131K 0.58% 40
2023
Q3 		$3.73M Buy
7,400
+114
+2% +$56.1K 0.59% 40
2023
Q2 		$3.5M Buy
7,286
+212
+3% +$104K 0.54% 45
2023
Q1 		$3.34M Buy
7,074
+56
+0.8% +$27K 0.57% 43
2022
Q4 		$3.72M Buy
7,018
+165
+2% +$87.4K 0.67% 38
2022
Q3 		$3.46M Sell
6,853
-135
-2% -$71K 0.65% 36
2022
Q2 		$3.59M Buy
6,988
+159
+2% +$79.8K 0.6% 41
2022
Q1 		$3.48M Buy
6,829
+260
+4% +$125K 0.49% 49
2021
Q4 		$3.3M Buy
6,569
+759
+13% +$344K 0.44% 56
2021
Q3 		$2.27M Buy
5,810
+334
+6% +$138K 0.34% 67
2021
Q2 		$2.19M Buy
5,476
+497
+10% +$198K 0.33% 68
2021
Q1 		$1.85M Buy
4,979
+494
+11% +$171K 0.31% 74
2020
Q4 		$1.57M Buy
4,485
+262
+6% +$87.8K 0.28% 74
2020
Q3 		$1.32M Sell
4,223
-80
-2% -$24.6K 0.28% 78
2020
Q2 		$1.27M Sell
4,303
-398
-8% -$114K 0.29% 76
2020
Q1 		$1.17M Buy
4,701
+110
+2% +$30.3K 0.31% 75
2019
Q4 		$1.35M Buy
4,591
+505
+12% +$132K 0.29% 76
2019
Q3 		$888K Buy
4,086
+80
+2% +$19.3K 0.21% 98
2019
Q2 		$978K Buy
4,006
+93
+2% +$22.4K 0.24% 93
2019
Q1 		$968K Buy
3,913
+120
+3% +$30.6K 0.28% 84
2018
Q4 		$945K Buy
3,793
+70
+2% +$18.5K 0.31% 79
2018
Q3 		$990K Hold
3,723
– – 0.29% 77
2018
Q2 		$913K Buy
3,723
+455
+14% +$109K 0.29% 78
2018
Q1 		$699K Buy
3,268
+441
+16% +$101K 0.23% 91
2017
Q4 		$623K Sell
2,827
-65
-2% -$13.8K 0.21% 99
2017
Q3 		$566K Buy
2,892
+190
+7% +$36.7K 0.21% 100
2017
Q2 		$501K Buy
2,702
+25
+0.9% +$4.38K 0.2% 97
2017
Q1 		$439K Hold
2,677
– – 0.18% 102
2016
Q4 		$428K Buy
+2,677
New +$400K 0.2% 99

Other funds holding UNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Abbrea Capital's UNH Position: Q2 2024 in Review

Abbrea Capital reduced its UnitedHealth (UNH) stake by 4.9% in Q2 2024, selling an estimated $186K and leaving 7,422 shares worth $3.78M. The position accounts for 0.5% of the portfolio, ranked #44.

Abbrea Capital first reported a position in UNH in Q4 2016 and has held it in 31 quarters since. The position peaked at $4.03M in Q4 2023. 3,395 funds tracked by Wall St. Rank hold UNH as of Q2 2024.

  • Abbrea Capital held 7,422 shares of UnitedHealth worth $3.78M as of Q2 2024.
  • Abbrea Capital sold 379 UnitedHealth shares in Q2 2024, an estimated $186K.
  • UnitedHealth made up 0.5% of Abbrea Capital's portfolio in Q2 2024, its #44 holding.
  • Abbrea Capital first reported a position in UnitedHealth in Q4 2016 and has held it in 31 quarters since.
  • Abbrea Capital's UnitedHealth position peaked at $4.03M in Q4 2023.
  • 3,395 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.